Have £1,000 to invest? Here are 2 monster growth stocks to consider

Harvey Jones reckons you could have a roaring time with these two growth monsters.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

You cannot top the excitement generated by a monster growth stock, and they don’t get more monster-ish than private healthcare operator NMC Health  (LSE: NMC). This is a 12-bagger over five years, its share price up a rampaging 1,111%.

Your good health

It is now a listed company with a market capitalisation of £8.25bn, so it would be unrealistic to expect another blast of 12-baggery, although it still has lots of momentum, rising 48% in the past 12 months alone. However, it has been trumped by a smaller company, The Gym Group (LSE: GYM), which is up 56% in the last year and today reported a strong first half with “growth across all key metrics”. My Foolish colleague Edward Sheldon predicted its success in January

The Gym Group, which runs 147 low-cost, no-contract gyms across the UK, reported a 36.1% rise in revenues to £58.3m, while group adjusted EBITDA rose 28% to £17.5m. That sounds good, but the stock actually fell around 2% on the news, as margins dipped from 32% to 30.1% year-on-year, reflecting immature estate profile and Lifestyle conversions”.

easyGym does it

Statutory profit before tax fell 14.4% to £5.1m, but that was down to an increase in exceptional costs to £1m, primarily relating to the acquisition of easyGym. Adjusted earnings per share (EPS) rose 7.8% to 4.2p, while the interim dividend went from 0.3p to 0.35p, a 16.7% increase.

So why are investors in a sweat? The £437m company trades at a pricey forward valuation of 34.5 times earnings, and at that hefty valuation, any interruption to the growth story is bound to jangle nerves. However, EPS projections look promising, with City analysts pencilling in 25% growth this year, and 37% in 2019. That should shrink the P/E to a more amenable 24.3 times earnings. The yield is just 0.5% but with cover of six, there is plenty of scope for progression.

The Gym Group continues to acquire new sites and is setting up a personal trainer programme, and although there are limits to growth with consumer pockets stretched at the moment, it looks in good shape.

Strong medicine

NMC Health issued its own half-year report and business update earlier this month to a much warmer welcome, with the stock bouncing 6% once investors had digested the numbers, which included a 20% rise in revenues and 30% increase in adjusted EPS.

Although it is London-listed it has little exposure to the flatlining UK private healthcare market, but instead focuses on the Gulf Cooperation Council (GCC), with an international reach that sees its doctors treat 8.5m patients across the UK, Spain, Italy, Denmark, Slovakia, Egypt, Brazil and Colombia.

Plenty of bite

Four years of double-digit EPS growth are expected to continue this year and next, with impressive projections of 35% in 2018 and 29% in 2019. NMC currently trades at an intimidating 48.7 times earnings but that strong anticipated growth should whittle it down to 27.5 times next year.

The forecast yield may be low at 0.5% but cover of 5.3 offers scope for progression, with management promising to be generous, with a policy of paying out 20%-30% of after-tax profits.

I think both these monsters may continue to roar.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

harveyj has no position in any of the shares mentioned. The Motley Fool UK has recommended NMC Health and The Gym Group. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

How I’d use an empty Stocks and Shares ISA to aim for a £1,000 monthly passive income

Here's how using a Stocks and Shares ISA really could help those of us who plan to invest for an…

Read more »

Investing Articles

This FTSE stock is up 20% and set for its best day ever! Time to buy?

This Fool takes a look at the half-year results from Burberry (LON:BRBY) to see if the struggling FTSE stock might…

Read more »

Investing Articles

This latest FTSE 100 dip could be an unmissable opportunity to pick up cut-price stocks

The FTSE 100 has pulled back with the government’s policy choices creating some negative sentiment. But this gives us a…

Read more »

A young woman sitting on a couch looking at a book in a quiet library space.
Investing Articles

As the WH Smith share price falls 4% on annual results, is it still worth considering?

WH Smith took a hit after this morning’s results left shareholders unimpressed. With the share price down 4%, Mark Hartley…

Read more »

Investing Articles

The Aviva share price just jumped 4.5% but still yields 7.02%! Time to buy?

A positive set of results has put fresh life into the Aviva share price. Harvey Jones says it offers bags…

Read more »

Investing Articles

Can a €500m buyback kickstart the Vodafone share price?

The Vodafone share price has been a loser for investors in recent years, and the dividend has been cut. We…

Read more »

Frustrated young white male looking disconsolate while sat on his sofa holding a beer
Growth Shares

3 mistakes I now avoid when choosing which growth stocks to buy

Jon Smith runs through some of the lessons he's learnt the hard way over the years about what to look…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

Should I follow Warren Buffett and sell my favourite shares?

Billionaire US investor Warren Buffett has been selling tons of Apple shares and other stocks of businesses he thinks are…

Read more »